David E. I. Pyott - 16 Jun 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Reporting relationship: Director
Issuer ticker: PLRX
Reported as of: 16 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jun 2022, 16:22:23 UTC
Prior SEC filing: 26 May 2022
Next SEC filing: 27 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Mike Ouimette, attorney-in-fact

Key filing fact

David E. I. Pyott filed Form 4 for PLIANT THERAPEUTICS, INC. (PLRX) on 21 Jun 2022.

Key facts

This page summarizes David E. I. Pyott's Form 4 filing for PLIANT THERAPEUTICS, INC. (PLRX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Jun 2022, 16:22.

Change

Previous filing in this sequence was filed on 26 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLRX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 16 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $6.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters beginning October 1st and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 16, 2022 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.